What python blood can teach us about weight loss, muscle health and gut bacteria

by Chief Editor

The Python’s Secret to Sustainable Weight Loss: A New Hope for Obesity Treatment?

The quest for effective and side-effect-free weight loss solutions may have an unlikely ally: the Burmese python. Scientists have identified a molecule in python blood, called para-tyramine-O-sulphate (pTOS), that appears to suppress appetite and promote weight loss in mice, potentially offering a new avenue for obesity treatment without the drawbacks of current medications.

The Extreme Metabolism of Pythons

Pythons are metabolic marvels. They can consume prey equivalent to 100% of their body weight in a single meal and then travel months, even years, without eating. Remarkably, they maintain heart and muscle health throughout these periods of feast and famine. This extraordinary ability sparked the interest of researchers at the University of Colorado Boulder, Stanford Medicine, and Baylor University.

Professor Leslie Leinwand’s team at CU Boulder, while studying the python’s digestive system, discovered that pTOS levels spike dramatically – over 1,000-fold – in the blood after a meal. This surge accompanies a 25% expansion of the python’s heart and a 4,000-fold increase in metabolism to facilitate digestion. Interestingly, pTOS too exists in humans, albeit at much lower levels, increasing two to five times after eating.

How pTOS Works: A Novel Satiety Signal

The body produces the amino acid tyrosine, which gut bacteria convert into tyramine. The liver then transforms tyramine into pTOS, which travels to the brain and signals satiety, effectively curbing appetite. This pathway was previously unknown, as common laboratory animals like mice and rats don’t naturally produce pTOS after eating, hindering earlier discovery.

Current weight-loss drugs, like Ozempic and Wegovy (GLP-1 receptor agonists), work by slowing digestion and regulating blood sugar. While effective, they often come with side effects such as nausea and digestive discomfort. PTOS offers a potentially different mechanism, focusing directly on signaling fullness to the brain.

Promising Results in Animal Studies

In studies conducted on mice, administration of pTOS led to reduced food intake and subsequent weight loss. Importantly, these effects were observed without significant changes in energy expenditure, movement, or blood sugar levels, suggesting a more metabolically benign approach to weight management. This suggests pTOS could be a promising avenue for obesity research.

However, researchers caution that the appetite-suppressing effect of pTOS may be diminished or absent in individuals with prediabetes or type 2 diabetes, indicating a potential impairment in the body’s natural fullness signaling in these conditions.

The Role of Gut Bacteria and Future Research

This discovery underscores the crucial role of gut bacteria in shaping metabolism and influencing brain signals related to appetite. Further research is needed to fully understand the complex interplay between gut microbiota, pTOS production, and metabolic regulation.

While pTOS has only been tested in mice so far, the findings open up exciting possibilities for developing new weight-loss therapies that mimic the natural satiety signals observed in pythons. The research, published in Nature Metabolism, solidifies the value of studying extreme physiological adaptations in the animal kingdom for potential human health benefits.

FAQ

Q: What is pTOS?
A: pTOS (para-tyramine-O-sulphate) is a molecule found in python blood that signals fullness to the brain, suppressing appetite.

Q: Has pTOS been tested in humans?
A: No, pTOS has only been tested in mice so far.

Q: Is pTOS a replacement for existing weight-loss drugs?
A: It’s too early to say. PTOS shows promise as a potential alternative, but further research is needed.

Q: What role do gut bacteria play in this process?
A: Gut bacteria convert tyrosine into tyramine, which the liver then transforms into pTOS.

Q: Could this research help people with diabetes?
A: The appetite-suppressing effect of pTOS may be reduced in people with prediabetes or type 2 diabetes.

Did you know? Snake venom has also been a source of clinically significant drugs, including medications for blood pressure and anticoagulation.

Explore more articles on metabolic health and innovative weight management strategies here. Subscribe to our newsletter for the latest updates in health and wellness!

You may also like

Leave a Comment